- Home
- SCOR vs ITRM Comparison
SCOR vs ITRM Comparison
Compare SCOR & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCOR
- ITRM
- Stock Information
- Founded
- SCOR 1999
- ITRM 2015
- Country
- SCOR United States
- ITRM Ireland
- Employees
- SCOR N/A
- ITRM N/A
- Industry
- SCOR Business Services
- ITRM Biotechnology: Pharmaceutical Preparations
- Sector
- SCOR Consumer Discretionary
- ITRM Health Care
- Exchange
- SCOR Nasdaq
- ITRM Nasdaq
- Market Cap
- SCOR 37.1M
- ITRM 40.0M
- IPO Year
- SCOR 2007
- ITRM 2018
- Fundamental
- Price
- SCOR $6.87
- ITRM $0.59
- Analyst Decision
- SCOR
- ITRM Strong Buy
- Analyst Count
- SCOR 0
- ITRM 1
- Target Price
- SCOR N/A
- ITRM $9.00
- AVG Volume (30 Days)
- SCOR 15.0K
- ITRM 808.5K
- Earning Date
- SCOR 11-04-2025
- ITRM 11-14-2025
- Dividend Yield
- SCOR N/A
- ITRM N/A
- EPS Growth
- SCOR N/A
- ITRM N/A
- EPS
- SCOR N/A
- ITRM N/A
- Revenue
- SCOR $358,940,000.00
- ITRM N/A
- Revenue This Year
- SCOR $3.45
- ITRM N/A
- Revenue Next Year
- SCOR $2.59
- ITRM $482.25
- P/E Ratio
- SCOR N/A
- ITRM N/A
- Revenue Growth
- SCOR 0.77
- ITRM N/A
- 52 Week Low
- SCOR $4.39
- ITRM $0.57
- 52 Week High
- SCOR $10.18
- ITRM $3.02
- Technical
- Relative Strength Index (RSI)
- SCOR 42.77
- ITRM 37.30
- Support Level
- SCOR $6.42
- ITRM $0.59
- Resistance Level
- SCOR $7.89
- ITRM $0.62
- Average True Range (ATR)
- SCOR 0.50
- ITRM 0.03
- MACD
- SCOR -0.09
- ITRM -0.01
- Stochastic Oscillator
- SCOR 23.81
- ITRM 14.87
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.